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Summary Steroid receptor was assessed immunohistochemically in 158 samples of normal breast for variation
through the menstrual cycle. Patterns and intensity of reaction were used in a semi-quantitative scoring system
to examine the influence of cycle phase, cycle type, parity and age. The changes in oestrogen receptor for
natural cycle and oral contraceptive (OC) cycles indicated down-regulation by progestins. Progesterone
receptor did not vary significantly in natural cycles, but increased steadily through OC cycles. This study
provides strong evidence that both oestrogen and progesterone influence breast epithelium, but dissimilarities
from the endometrium are apparent. The interval since pregnancy had a significant negative effect on
frequency and score of oestrogen receptor and score of progesterone receptor. Multivariate analysis established
the phase of cycle and OC use as independent significant influences on oestrogen receptor. The interval since
pregnancy was an independent significant factor for both oestrogen and progesterone receptor presence.
Female sex steroids, oestrogens and progestins, influence the
normal human breast, but controversy exists as to the nature
of those effects, especially in relation to cell proliferation
(McCarty, 1989; King, 1990). In part, the controversy reflects
the difference in data derived from tissues obtained ex vivo
from those derived from cell culture and from xenografts in
nude mice, but another factor has been the assumption of
similarity in the steroidal regulation of breast and endome-
trial epithelia. While a clear picture of oestrogen receptor and
progesterone receptor regulation exists for endometrium
(Lessey et al., 1988), the same is not true for breast. Oestro-
gen and progesterone receptors (OR and PR) are both pres-
ent in normal human breast epithelium (Petersen et al., 1987;
Jacquemier et al., 1990; Joyeux et al., 1990; Williams et al.,
1991) but with lack of agreement between authors as to
differences across the cycle or consistency within it. To help
clarify the situation, we have carried out an immunohisto-
chemical analysis of OR and PR in histologically normal
breast tissue, related the findings to phase of the menstrual
cycle, oral contraceptive (OC) use, age and parity. These
factors have been demonstrated previously to have a major
effect on breast proliferation (Anderson et al., 1989). Inform-
ation on the influence of OC on breast OR and PR is
relevant, in view of the importance of this topic in relation to
the genesis of breast cancer (Thomas, 1991). This report
addresses these issues and includes a morphological evalua-
tion of the patterns and distribution of receptor staining
within the breast parenchyma.
Materials and methods
Breast tissue was obtained from 158 premenopausal women
undergoing biopsy for clinical reasons, as described pre-
viously (Anderson et al., 1989). Samples of histologically
normal tissue were taken from areas adjacent to fibro-
adenomas (62%), minimal fibrocystic change (14%) or from
specimens in which no significant histopathology was identi-
fied (24%). Menstrual cycle and obstetric history were
obtained on the day of biopsy and menstrual cycle length
identified by postal returns was normalised to 28 days
(Anderson et al., 1989). The menstrual cycle was divided into
'weeks' of unequal length, to take account of days on and off
OC, as described previously (Anderson et al., 1989).
Tissue preparation
Fresh biopsy specimens were transported to the laboratory
on ice and areas of normal breast tissue (10 mm x 10 mm x
3 mm) were snap frozen in isopentane in liquid nitrogen and
stored at - 80°C until use. Adjacent areas were fixed in
methacarn fixative (methanol: chloroform: acetic acid, 6:3:1)
at 4°C and processed to paraffin wax.
For immunohistochemical localisation of OR and PR,
cryostat sections were obtained and fixed in Zamboni's
fixative (Stefanini et al., 1967) for 15 min at - 20°C and
stored in glycerol/sucrose buffer (Abbott ER-ICA handbook)
at - 20°C until use. Sections of methacarn fixed, paraffin
embedded material were cut at 4 lm and low temperature
dried.
Immunohistochemistry
Oestrogen receptor localisation was performed using the ER-
ICA rat monoclonal antibody (H222) to the OR (Abbott).
Staining was performed either on frozen sections using the
ER-ICA kit reagents or on methacarn fixed paraffin sections,
using a modification of the method of Shintaku and Said
(1987), previously shown to give comparable results to frozen
sections in breast carcinomas (Paterson et al., 1990). Briefly,
dewaxed sections were treated with DNAase, followed by
overnight incubation at 4°C with the primary antibody. After
washing, sections were incubated sequentially with biotiny-
lated goat anti-rat immunoglobulins (Sigma) and a strepta-
vidin-biotin peroxidase complex (Amersham). The reaction
was visualised with diaminobenzidine. Progesterone receptor
was localised on cryostat sections using a mouse monoclonal
antibody raised against rabbit uterine PR (Transbio, Paris),
shown to exhibit a high affinity against the human PR (Helin
et al., 1988). The antibody was used at a dilution of 10 g
ml-' and detection was by an indirect immunoperoxidase
method (Dako). An Abbott ER-ICA control section and a
section of a breast carcinoma with a high level of PR, as
determined biochemically, were included in each experiment
as positive controls for OR and PR respectively.
Scoring
One tissue section was examined in each case, and all ter-
minal duct lobular units (TDLU) present were assessed
(range = 6-78, mean 29, for paraffin sections and range =
5-29, mean 11, for frozen sections). Initially cases were
scored on a simple positive or negative basis for dark brown
chromogen reactivity, consisting of a minimum of 5% of
nuclei in any parenchymal structure. Staining within the
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extralobular portion of the terminal duct (ELTD) was also
evaluated, but was not included in the score. From the
preliminary qualitative assessment of immunostaining, a
semi-quantitative scoring system was developed to take
account of three major variables considered to be important.
These were: (1) the intensity of staining, (2) the percentage of
TDLU showing reactivity, and (3) the morphological pattern
of reactivity within the TDLU. If less than 5% of cells in a
TDLU were reactive, it was considered as negatively stained.
Intensity of reactivity was divided into three grades, where
I = weak or equivocal, 2 = moderate and 3 = strong. The
pattern of reactivity was graded as 1 if staining within a
TDLU was of the sporadic type and 2 if greater than 30% of
cells were positive, usually corresponding to a 'ring' of posi-
tive reacting cells within ductules. The score was calculated
using a modification of a previously published summation
equation (McCarty et al., 1985).
Score= I Pip (i +p + 1)
Pip = percentage of TDLU stained for each pattern and
intensity.
where i= intensity of staining = 1, 2 or 3
p = pattern of staining = 1 (sporadic) or 2 ('ring-like')
Non-reactive TDLU, while contributing to the calculation of
the percentage of positively staining units in the overall
summation, were given a score of 0. As an illustration, taking
a case with 5 TDLU with negative staining, 5 of sporadic
pattern at intensity 2, 5 of sporadic pattern at intensity 3 and
10 with a 'ring-like' pattern at intensity 1 results in a score of
20 x 0 + 20(2 + 1 + 1) + 20(3 + 1 + 1) + 40(1 + 2 + 1) = 340
Twenty-five cases were examined independently by two
observers and the scores obtained showed a significant con-
cordance (t = 0.723, P = 0.00003, Kendall Rank Correlation).
Intraobserver correlation was also highly significant (T = 0.96,
P = 0.00007).
Statistical methods
For univariate analysis the chi squared (x2) test of signi-
ficance was applied to the postive/negative scored data set
out in contingency tables. Semi-quantitative scores were com-
pared using the Mann-Whitney U test with corrections made
for ties. Multiple logistic regression and multiple regression
were used with GLIM statistical software (NAC Computing
Oxford, England).
Results
Location andpatterns ofsteroid receptor staining
Immunohistochemistry for OR was performed in 158 cases.
Staining was undertaken either on cryostat sections only (48),
on paraffin sections only (63) or by both methods (47). OR
staining was confined to luminal and intermediate epithelial
cell nuclei and a highly significant concordance (P<0.001)
was seen, comparing staining on paraffin and cryostat sec-
tions. However, in five cases, positive reactivity was seen on
paraffin sections, but not on cryostat sections from adjacent
areas of breast tissue. The positive methacarn value was
accepted, because the paraffin section gave a larger sample
with a validated technique. Cases which were evaluated only
on cryostat sections were equally distributed amongst various
groups, e.g. OC users, nulliparous.
A total of 133 of the cases used above were stained for PR,
using cryostat sections only. Steroid receptor detection was
always nuclear in location and although predominantly in the
luminal epithelial component of the TDLU, reactivity of the
basal myoepithelial cells was also occasionally noted. In a
low proportion of those cases where adjacent cryostat sec-
tions were stained for OR and PR particular TDLU were
positively reactive for both antigens. In these cases staining
was frequently of the 'ring-like' pattern described below.
The distribution of receptor staining for both steroids was
heterogeneous within the tissue sample and in more than
80% of positive cases both positively and negatively stained
TDLUs were seen on sections examined. In a few cases only
one TDLU showed reactivity. Both positive and negative
receptor reactivity was seen in the ELTD, with a positively
reactive duct usually associated with at least one positively
staining TDLU. Staining showed two morphological patterns;
a sporadic pattern, where 5-30% of nuclei within a TDLU
were reactive (Figure 1) or a 'ring-like' pattern, where more
than 30% of nuclei showed positive staining (Figure 2).
Although initial examination suggested that the 'ring-like'
pattern was often intensely staining, formal analysis gave no
significant relationship between the pattern and intensity of
staining. Figures 1 and 2 specifically illustrate PR staining,
but patterns of OR staining were very similar. Appreciation
of the variations in staining pattern led to the development of
a semi-quantitative scoring system which took pattern of
reactivity into account as well as the more commonly assess-
ed parameters of staining intensity and frequency.
The results (Tables I and II) were set down in specific case
groupings, with receptor immunoreactivity assessed in two
ways, either (1) the proportion of cases reactive, or (2)
receptor scores. As regards the first, OR reactivity was pre-
sent in 60 out of 158 (38%) of cases, while 96 out of 133
(72%) of cases were PR positive. Considering the second, OR
scores ranged from 0 to 513 (median = 0), while for PR a
range of 0 to 600 (median = 186) was seen. The following
sections deal with aspects of staining for OR and PR,
examining specifically the effects of menstrual cycle phase
and type (i.e. natural or OC) as well as considering the
influence of age and parity.
Oestrogen receptor detection
Effect of menstrual cycle type and day In the natural cycle,
47% of cases showed positive immunoreactivity for the OR.
Figure 1 Sporadic pattern ofprogesterone receptor immunoreac-
tivity in epithelial nuclei of breast TDLU, x 320.STEROID HORMONE RECEPTOR IN NORMAL BREAST 603
Figure 2 'Ring-like' progesterone receptor staining of luminal
epithelial cell nuclei in normal breast, x 320.
When cases were assessed on a simple positive or negative
basis, significantly more positive cases were seen on days
1- 13 (61%) compared with days 14-28 (34%) (P = 0.02).
However, taking the more quantitative approach to assess-
ment in terms of OR scores (Table I), the range of positive
values seen on comparing days 1-13 (8-406) and 14-28
(54-410) was similar; median scores did not differ signi-
ficantly. Yet, the distribution of scores was not even through
the cycle. To examine this in more detail an arbitrary cut-off
score for high values was taken at 200, to give three levels,
namely negative, low-moderate and high as displayed in
Figure 3, which also details the number of cases included in
each time period. This illustrated a highly significant decrease
in the proportion of low to moderate scores in the second
half of the cycle (P = 0.0001), with an equivalent increase in
negative cases. The proportion of high scoring cases (>200)
stayed the same throughout.
Looking at OC use, only 26% of cases gave positive OR
detection, although the range of positive OR scores (9-417)
was similar to that in the natural cycle. Overall, reactivity
was significantly less frequent than in the natural menstrual
cycle, either assessed as a proportion of positive cases
(P = 0.005) or as a score according to positive and negative
cases (P = 0.014) (Tables I and II). The decrease in positive
reactivity represented a significant decrease in both high
(P<0.001) and low to moderate (P<0.02) scoring cases
(Figure 3). In this group, no clear differences emerged for
OR comparing days 1-13 with days 14-28 of the cycle
(Tables I and II). There was a non-significant trend for more
frequent OR detection in the week off OC.
Effect of age and parity The influence of age on OR detec-
tion was considered in two ways, either as chronological age
(time since birth) or breast age (time since menarche). In
neither instance was there a significant influence on OR
immunoreactivity. This was true for both natural and arti-
ficial (OC) cycles. Similarly, comparing nulliparous and
parous groups no differences were apparent in receptor detec-
tion in natural cycles or during OC use (Table I). Yet con-
sidering only parous women and in the natural cycle, the
interval since last pregnancy had an effect on both the pro-
portion of OR positive cases and levels of OR scores. For
example, positive OR reactivity was noted in only two of 13
cases from women, 2 years post partum (positive scores=
237 + 331). Expanding the cut-off to 5 years to give greater
numbers for statistical analysis, positive cases were signi-
ficantly more frequent (P = 0.005) and the median score was
higher (P = 0.0002) in breast tissue from women whose last
pregnancy was > 5 years compared with those who had been
pregnant within the last 5 years. From this type of subgroup
analysis, it was not known whether the significant difference
represented an increase in detection amongst those > 5 years
post partum or a decrease in those more recently parous.
This problem was overcome by multivariate analysis (see
below), which also allowed phases of menstrual cycle and OC
use to be taken into account when considering age or parity.
Progesterone receptor detection
Effect of menstrual cycle type and day In the natural cycle,
more than 70% of cases showed positive immunoreactivity
for PR. When cases were assessed either on a simple positive/
negative basis or in terms of a PR score, no significant
differences were seen comparing days 1-13 of the cycle with
days 14-28 (Table I). Taking the same division at 200 as for
OR, a large proportion of positive cases were in the high
(>200 group) (Figure 4). This reflected the arbitrary nature
of the cut-off, which may have a different significance for PR
than for OR.
Considering OC use, PR was detected with similar fre-
quency to that seen in the natural cycle (>70%). For OC
users, the median PR score was significantly higher on days
14-28 of the cycle compared with days 1-13 (Tables I and
II). Looking across the entire OC cycle, there was a steady
rise in high scoring PR positive cases (>200) progressing
from week 1 (days 1-5) to week 4 (21-28) (Figure 4), with a
significant increase on days 14-28 compared with days 1-13
(P<0.05). This increase was accompanied by a decrease in
both negative and low to moderate cases.
Effect of age and parity As for OR, neither chronological
age nor breast age influenced PR detection. However in the
natural cycle, there was a non-significant trend (P = 0.078)
for PR scores to be lower amongst parous women. As before,
looking at the effect ofinterval since pregnancy in the natural
cycle a low proportion (2/11) of women <2 years post
partum showed positive PR reactivity (positive scores 412 +
233).
Adopting the same division as oestrogen, at 5 years the
proportion of positive cases did not differ significantly. How-
ever, those who were parous within 5 years showed a signifi-
cantly lower (P = 0.009) median PR score than those pregnant
5 or more years previously (Tables I and II). The effect is
examined in more detail below by multivariate analysis.
Multivariate analysis
Multivariate analysis was performed for cases scored on a
simple positive or negative basis and findings are presented in
Table III. Adjusting for phase of the menstrual cycle, OC use
had a significant negative influence on the frequency of OR
positivity. Breast age and parity did not influence the fre-
quency of receptor positive detection, when adjusted for cycle
phase and oral contraceptive use, but time since pregnancy
was a highly significant influencing factor. Compared with
nulliparous, those less than 5 years post partum were less
frequently OR positive, while those 5-10 years following
pregnancy showed a much higher frequency of detection.
For PR, phase of the menstrual cycle, OC use and breast
age had no significant influence, yet the reduction in the604 S. BATTERSBY et al.
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Table II Levels of significance for comparisons in Table I
Positive
percentage Postive score
x2_ test (Mann-Whitney U test)
Oestrogen receptor
Phase of natural cycle 0.02 NS
Type of cycle (nat vs OC) 0.005 0.014
Interval since pregnancy 0.005 0.0002
Progesterone receptor
Phase of OC cycle NS 0.05
Type of cycle (nat vs OC) NS NS
Interval since pregnancy NS 0.0009
NS = not significant.
Progesterone receptor
100
80
cn 60
cn
- 40
20
Oestrogen receptor
100 -
80 -
0 Natural
Natural
1-5(13) 6-13(21) 14-20(17) 21-28(18)
Day of cycle (No. of cases)
100 -
80 -
co 60 -
a)
Cn
- 40-
1-5(14) 6-13(27) 14-20(20) 21-28(24)
Day of cycle (No. of cases) 20 -
0
Artificial (OC)
1-5(12) 6-13(17) 14-20(13) 21-28(19)
Day of cycle (No. of cases)
Figure 4 Distribution of cases stained for progesterone receptor
according to proportion of negative (0), low-moderate (<200)
and high (>200) scores across natural and artifical (OC) mens-
trual cycles. (@-*) Negative, (O *) Low-mod, (A-A)
High.
1-5(13) 6-13(19) 14-20(16) 21-28(20)
Day of cycle (No. of cases)
Figure 3 Distribution of cases stained for oestrogen receptor
according to proportion of negative (0), low-moderate (<200)
and high (. 200) scores across natural and artificial (OC) mens-
trual cycles. (0-0) Negative, (U *) Low-mod, (A-A)
High.
frequency of PR positive cases among parous women
approached significance (Table III). Time since last preg-
nancy did have an independent effect on the likelihood of PR
positivity, in that there was a significant reduction in positive
cases amongst those <5 years post partum compared with
nulliparous individuals.
Looking at OC formulation, classified as described pre-
viously (Anderson et al., 1989), after adjustment for phase of
cycle, OC use and time since last pregnancy, there was no
significant effect of oestrogen or progestogen content on
proportion of positive cases.
Table III Multivariate analysis of factors affecting oestrogen and progesterone receptor
detection
Oestrogen receptor Progesterone receptor
x2 ddf. P< x2 d.f. P<
Phase of cycle 11.95 4 0.05 2.64 4 NS
Adjusting for phase
Current OC use 8.80 1 0.01 0.10 1 NS
Adjusting for OC use
Parity 1.91 1 NS 3.70 1 0.10
Interv since last preg 17.84 2 0.0001 12.10 2 0.01
Adjusting for time since last pregnancy
Breast age 3.20 5 NS 2.02 2 NS
Oestrogen content of OC 2.80 4 NS 5.45 4 NS
Progestogen content of OC 2.70 5 NS 5.70 4 NS
c, 60-
a)
cn (a
0
- 40-
20 -
0
100
80-
co 60- )0
0
--,- 40Q-
20 -
0
Artificial (OC)
. . .
I
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A complicating factor for multivariate analysis of receptor
scores was the high frequency of negative cases. However,
taking only those cases postive, results could be analysed
according to receptor scores. No effect on OR or PR level
was seen for any of the parameters tested, yet it must be
noted that omission of negatives made case numbers small.
Discussion
This study agrees with previous reports of OR and PR
reactivity in epithelial cell nuclei of normal breast tissue,
commonly expressed as a low proportion of positive cells
(Petersen et al., 1987; Jacquemier et al., 1990; Joyeux et al.,
1990). We now extend the observations through a semi-
quantitative evaluation that acknowledges not only the func-
tional integrity of TDLU as units of response, but also the
heterogeneity of immunoreactive receptor presence, both
within and between the units. Such factors have not pre-
viously been considered and provide a different perspective
for interpretation of breast response.
For OR, the significant excess of cases with positive reac-
tive tissues seen in the first half of the menstrual cycle has
been noted previously both on biochemical (Silva et al., 1983)
and immunohistochemical (Williams et al., 1991) assessment
as well as on needle aspirated breast cells (Markopoulos et
al., 1988). Thus, with the addition of the present results, it
would appear that the prominence of OR within the first half
of the cycle is established. However, it must be noted that
two immunohistochemical studies have shown no correlation
between cycle phase and OR detection (Carpenter et al.,
1989; Jacquemier et al., 1990). This may be because in the
study of Carpenter et al. (1989), assignment of breast tissue
to phases of cycle was based on histological grounds (Vogel
et al., 1981) rather than specific calendar dates, as in the
present series, while the study of Jacquemier et al. (1990) was
based on a series of only 15 cases.
The decrease in OR positive cases in the second half of the
menstrual cycle is the same as the endometrium (Press et al.,
1984; Lessey et al., 1988) and is consistent with the accepted
dogma of OR down-regulation as a consequence of proges-
terone action. The present study further supports this from
observations in OC cycle, where there is a striking decrease
in detection with use, presumably on account of down-
regulation by exogenous progestins. However, the present
data do not enable an evaluation of any contribution to the
down-regulation by oestrogen itself. The utility of the scoring
system has been to demonstrate that there are two patterns
of staining, one of which is constant in the natural cycle and
the other which varies. Since the biopsy samples are solitary
and not sequential, there are major limitations on the infer-
ences to be drawn from these patterns in terms of epithelial
response and activity.
The current literature on PR in normal breast epithelium is
sparse, with only one report of 15 cases (Jacquemier et al.,
1990) indicating menstrual cycle variation, with an increase
in the secretory phase. Two other reports (Joyeux et al.,
1990; Williams et al., 1991) show no change through the
cycle. Our data agree with the latter publications, although
we cannot rule out a small, but statistically insignificant
oestrogen-related increase in staining during the late pro-
liferative stage of the natural cycle. Of considerable interest is
the detection by the scoring system of a significant stimu-
latory effect of OC use on PR staining, with increasing days
of use. This is difficult to interpret, but as most OC types
used by women in this study contained oestrogen in addition
to progestin, it is possible that the rise reflects an oestrogenic
effect not counteracted by the progestin component. How-
ever, the absence of such an effect in the natural cycle is
against that idea. Further anlaysis of epithelia in women
taking progestin only OC may help to resolve the problem,
but there is the caveat that significant ovarian follicular
function occurs within this group (Howie, 1985). What is
clear from our data is that neither endogenous (natural) or
exogenous (OC) progestins dramatically down-regulate breast
epithelial PR. This contrasts with endometrial receptors
(Press et al., 1988) and thus provides another example in
which these two types of epithelium differ.
This study does not specifically address the issue of steriod
receptor reactivity and proliferation, and thus no direct com-
ment is offered upon the role, if any, of progesterone as such
a breast stimulant. Nevertheless, the suggestion that proges-
tins promote cell division is supported by studies of fatty acid
synthetase, a marker of progesterone response (Chalbos et
al., 1987). This enzyme shows increased localisation in nor-
mal breast epithelium in the second half of the menstrual
cycle (Joyeux et al., 1990) and an association has been
reported with proliferative varieties of benign breast lesions
(Chalbos et al., 1990). Yet in vitro studies with explants in
nude mice have demonstrated a stimulant effect of oestrogen
on normal breast epithelial proliferation, while progesterone
has no effect (McManus & Welsch, 1984; Laidlaw et al.,
1990). Resolving these differences is challenging. As we have
previously shown, there are several variables significantly
influencing 3H thymidine uptake in ex vivo normal breast
(Anderson et al., 1989). It thus appears unduly simplistic to
suggest that proliferative activity in this tissue is controlled
by either steroid acting alone. Indeed, it may be that the
ratio of oestrogen to progesterone is critical in modulating
the levels of receptor expressed and ultimately the level of
proliferation, whether stimulated either directly or indirectly
by steroid action or via other growth factors. However, our
current data do not help to resolve the question of which
female sex steroid hormones are the prime regulators of
normal breast epithelial proliferation (King, 1990).
The present study of receptor variations during menstrual
cycles has revealed several idiosyncratic features concerning
breast responses that suggest approaches emphasising local
factors should be followed. As in the case of proliferation
(Anderson et al., 1989), multivariate analysis of the present
data has identified independent variables influencing steroid
receptor expression, of which time since pregnancy shows a
major effect. This is further evidence for an altered tissue
environment following pregnancy, as already suggested from
the decrease in proliferative response in breast tissue from
parous OC users (Anderson et al., 1989). It is also supported
by the very low incidence of OR and PR detection seen in
breast tissue from women < 2 years post-pregnancy. The
pregnancy effect may be the result of variations in tissue
hormonal environment or altered responsiveness to this envir-
onment. Certainly, there is evidence from nipple aspirates for
a decrease in local oestrogen content of breast tissue among
those less than 5 years post-pregnancy (Petrakis et al., 1987).
Alternatively, an explanation for altered steroid receptor
reactivity can be based on histology, from the observation
that, in a proportion of women following pregnancy, breast
TDLU show a markedly atrophic morphological appearance
recognisable up to 5 years post partum (Battersby & Ander-
son, 1989). This would readily account for refractory
behaviour of TDLU to local endocrine factors. An under-
standing of the mechanisms by which these alterations are
achieved and sustained may be crucial in explaining the
decrease in breast cancer risk associated with an early preg-
nancy (MacMahon et al., 1970).
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